Toshiaki Yoshimoto Selected Research

Toshiaki Yoshimoto Research Topics

17	Neoplasms (Cancer) 01/2024 - 01/2017
13	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2021
9	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2021
6	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 03/2020
5	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2017
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2020
3	Inguinal Hernia (Direct Inguinal Hernia) 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 01/2020
2	Lymphatic Metastasis 03/2024 - 12/2022
2	Frailty 01/2023 - 09/2022
1	Pancreatic Fistula (Pancreatic Fistulas) 02/2024
1	Hemorrhage 02/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Metabolic Bone Diseases (Osteopenia) 09/2022
1	Neutropenia 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022
1	Liver Neoplasms (Liver Cancer) 07/2022
1	Cholangiocarcinoma 07/2022
1	Adenocarcinoma 04/2022
1	Ileus 04/2022
1	Body Weight (Weight, Body) 09/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2021
1	Situs Inversus 04/2021
1	Obesity 01/2021
1	Pathologic Constriction (Stenosis) 12/2020
1	Hyperglycemia 09/2020
1	Hypoglycemia (Reactive Hypoglycemia) 09/2020
1	Intestinal Perforation 03/2020
1	Necrosis 01/2020
1	Liver Failure 01/2019
1	Colonic Neoplasms (Colon Cancer) 03/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Bile Duct Adenoma 01/2017
1	Duodenal Ulcer (Curling's Ulcer) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2017
1	Papillary Adenocarcinoma 01/2017

4	Indicators and Reagents (Reagents)IBA 04/2024 - 01/2017
4	CytokinesIBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2024 - 01/2021
2	OpsinsIBA 05/2022 - 03/2018
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 05/2021 - 03/2020
2	tetra-4-amidinophenoxypropane (TAPP)IBA 01/2020 - 01/2020
1	Amylases FDA Link 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Phenobarbital (Luminal)FDA Link 11/2022
1	sudachitinIBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 06/2022
1	AlbuminsIBA 03/2022
1	Insulin (Novolin)FDA Link 01/2022
1	C-Reactive ProteinIBA 07/2021
1	fibrin fragment D (D-dimer)IBA 06/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2021
1	PyrrolesIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 09/2020
1	InterferonsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2019
1	GadoliniumIBA 01/2019
1	NF023IBA 03/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Carcinoembryonic AntigenIBA 01/2017
1	CEACAM1 ProteinIBA 01/2017

15	Gastrectomy 05/2023 - 01/2017
5	Therapeutics 12/2021 - 01/2018
4	Chemoradiotherapy 04/2024 - 01/2021
4	Drug Therapy (Chemotherapy) 04/2024 - 01/2022
3	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 06/2022
3	Hepatectomy 01/2019 - 01/2017
2	Operative Surgical Procedures 12/2022 - 06/2022
2	Neoadjuvant Therapy 11/2022 - 03/2020
1	Operative Time 01/2024
1	Renal Dialysis (Hemodialysis) 05/2023
1	Minimally Invasive Surgical Procedures 03/2023
1	Bariatric Surgery 01/2023
1	Computer-Assisted Surgery (Image Guided Surgery) 09/2022
1	Adjuvant Chemotherapy 04/2022
1	Ileostomy 04/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Caloric Restriction 09/2021
1	Radiotherapy 07/2021
1	Pancreatectomy 09/2020
1	Artificial Pancreas 09/2020
1	Glycemic Control 09/2020